AXSM · Categories · Form 4
AXSM - SEC Form 4 insider transactions
Axsome Therapeutics Inc. (AXSM) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.
Recent Form 4 for AXSM
- Director Saad Mark E converted options into 1,429 shares, increasing direct ownership by 14% to 11,431 units (SEC Form 4)4 - Axsome Therapeutics, Inc. (0001579428) (Issuer)
- Director Jeffs Roger converted options into 1,429 shares, increasing direct ownership by 2% to 58,939 units (SEC Form 4)4 - Axsome Therapeutics, Inc. (0001579428) (Issuer)
- Director Mahony Susan converted options into 1,429 shares and sold $145,017 worth of shares (600 units at $241.69) as part of a pre-agreed trading plan (SEC Form 4)4 - Axsome Therapeutics, Inc. (0001579428) (Issuer)
- Director Coleman Mark converted options into 1,429 shares and sold $160,107 worth of shares (643 units at $249.00) as part of a pre-agreed trading plan, increasing direct ownership by 3% to 30,389 units (SEC Form 4)4 - Axsome Therapeutics, Inc. (0001579428) (Issuer)
- SEC Form 4 filed by Director Coleman Mark4 - Axsome Therapeutics, Inc. (0001579428) (Issuer)
- SEC Form 4 filed by Director Mahony Susan4 - Axsome Therapeutics, Inc. (0001579428) (Issuer)
- Chief Executive Officer Tabuteau Herriot exercised 49,670 shares at a strike of $4.95 and sold $11,970,967 worth of shares (49,670 units at $241.01) as part of a pre-agreed trading plan (SEC Form 4)4 - Axsome Therapeutics, Inc. (0001579428) (Issuer)
- Chief Financial Officer Pizzie Nick exercised 33,000 shares at a strike of $3.50 and sold $7,922,970 worth of shares (33,000 units at $240.09) as part of a pre-agreed trading plan (SEC Form 4)4 - Axsome Therapeutics, Inc. (0001579428) (Issuer)
- SEC Form 4 filed by Director Saad Mark E4 - Axsome Therapeutics, Inc. (0001579428) (Issuer)
- SEC Form 4 filed by Director Jeffs Roger4 - Axsome Therapeutics, Inc. (0001579428) (Issuer)
- Director Coleman Mark sold $4,019,470 worth of shares (17,537 units at $229.20) as part of a pre-agreed trading plan, decreasing direct ownership by 37% to 29,603 units (SEC Form 4)4 - Axsome Therapeutics, Inc. (0001579428) (Issuer)
- Chief Operating Officer Jacobson Mark L. exercised 4,750 shares at a strike of $12.95 and sold $1,082,771 worth of shares (4,750 units at $227.95) as part of a pre-agreed trading plan (SEC Form 4)4 - Axsome Therapeutics, Inc. (0001579428) (Issuer)
- SEC Form 4 filed by Chief Operating Officer Jacobson Mark L.4 - Axsome Therapeutics, Inc. (0001579428) (Issuer)
- SEC Form 4 filed by Chief Executive Officer Tabuteau Herriot4 - Axsome Therapeutics, Inc. (0001579428) (Issuer)
- Chief Commercial Officer Maizel Ari exercised 7,500 shares at a strike of $70.73 and sold $1,368,150 worth of shares (7,500 units at $182.42) as part of a pre-agreed trading plan (SEC Form 4)4 - Axsome Therapeutics, Inc. (0001579428) (Issuer)
- SEC Form 4 filed by Chief Commercial Officer Maizel Ari4 - Axsome Therapeutics, Inc. (0001579428) (Issuer)
- SEC Form 4 filed by Chief Financial Officer Pizzie Nick4 - Axsome Therapeutics, Inc. (0001579428) (Issuer)
- SEC Form 4 filed by General Counsel Murdock Hunter R.4 - Axsome Therapeutics, Inc. (0001579428) (Issuer)
- SEC Form 4 filed by Chief Executive Officer Tabuteau Herriot4 - Axsome Therapeutics, Inc. (0001579428) (Issuer)
- SEC Form 4 filed by General Counsel Murdock Hunter R.4 - Axsome Therapeutics, Inc. (0001579428) (Issuer)
- SEC Form 4 filed by Chief Commercial Officer Maizel Ari4 - Axsome Therapeutics, Inc. (0001579428) (Issuer)
- SEC Form 4 filed by Chief Operating Officer Jacobson Mark L.4 - Axsome Therapeutics, Inc. (0001579428) (Issuer)
- SEC Form 4 filed by Chief Financial Officer Pizzie Nick4 - Axsome Therapeutics, Inc. (0001579428) (Issuer)
- Chief Operating Officer Jacobson Mark L. exercised 35,378 shares at a strike of $2.85 and sold $5,726,991 worth of shares (35,378 units at $161.88) (SEC Form 4)4 - Axsome Therapeutics, Inc. (0001579428) (Issuer)
- Director Coleman Mark sold $4,027,750 worth of shares (25,000 units at $161.11), decreasing direct ownership by 35% to 47,140 units (SEC Form 4)4 - Axsome Therapeutics, Inc. (0001579428) (Issuer)
- Director Coleman Mark exercised 6,250 shares at a strike of $4.95, increasing direct ownership by 9% to 72,140 units (SEC Form 4)4 - Axsome Therapeutics, Inc. (0001579428) (Issuer)
- Director Coleman Mark exercised 12,485 shares at a strike of $4.95, increasing direct ownership by 23% to 65,890 units (SEC Form 4)4 - Axsome Therapeutics, Inc. (0001579428) (Issuer)
- Director Coleman Mark exercised 5,193 shares at a strike of $8.02, increasing direct ownership by 11% to 53,405 units (SEC Form 4)4 - Axsome Therapeutics, Inc. (0001579428) (Issuer)
- Chief Executive Officer Tabuteau Herriot exercised 32,410 shares at a strike of $8.02 and sold $6,015,296 worth of shares (32,410 units at $185.60) (SEC Form 4)4 - Axsome Therapeutics, Inc. (0001579428) (Issuer)
- Chief Financial Officer Pizzie Nick exercised 12,000 shares at a strike of $3.50 and sold $2,255,040 worth of shares (12,000 units at $187.92) (SEC Form 4)4 - Axsome Therapeutics, Inc. (0001579428) (Issuer)
- Chief Commercial Officer Maizel Ari exercised 7,500 shares at a strike of $70.73 and sold $1,383,300 worth of shares (7,500 units at $184.44) (SEC Form 4)4 - Axsome Therapeutics, Inc. (0001579428) (Issuer)
- Chief Executive Officer Tabuteau Herriot exercised 139,414 shares at a strike of $8.02 and sold $23,881,618 worth of shares (139,414 units at $171.30) (SEC Form 4)4 - Axsome Therapeutics, Inc. (0001579428) (Issuer)
- Director Saad Mark E exercised 37,577 shares at a strike of $5.46 and sold $6,206,969 worth of shares (37,577 units at $165.18) (SEC Form 4)4 - Axsome Therapeutics, Inc. (0001579428) (Issuer)
- Chief Executive Officer Tabuteau Herriot sold $11,648,582 worth of shares (79,973 units at $145.66) and exercised 79,973 shares at a strike of $8.02 (SEC Form 4)4 - Axsome Therapeutics, Inc. (0001579428) (Issuer)
- Chief Executive Officer Tabuteau Herriot exercised 163,939 shares at a strike of $8.02 and sold $21,815,669 worth of shares (163,939 units at $133.07) (SEC Form 4)4 - Axsome Therapeutics, Inc. (0001579428) (Issuer)
- Chief Executive Officer Tabuteau Herriot exercised 45,384 shares at a strike of $8.02 and sold $5,418,060 worth of shares (45,384 units at $119.38) (SEC Form 4)4 - Axsome Therapeutics, Inc. (0001579428) (Issuer)
- Chief Operating Officer Jacobson Mark L. exercised 10,000 shares at a strike of $2.85 and sold $1,159,600 worth of shares (10,000 units at $115.96) (SEC Form 4)4 - Axsome Therapeutics, Inc. (0001579428) (Issuer)
- Chief Operating Officer Jacobson Mark L. sold $5,241,127 worth of shares (45,783 units at $114.48) and exercised 40,000 shares at a strike of $4.91, closing all direct ownership in the company (SEC Form 4)4 - Axsome Therapeutics, Inc. (0001579428) (Issuer)
- Chief Executive Officer Tabuteau Herriot exercised 62,880 shares at a strike of $8.02 and sold $7,361,891 worth of shares (62,880 units at $117.08) (SEC Form 4)4 - Axsome Therapeutics, Inc. (0001579428) (Issuer)
- Director Saad Mark E exercised 9,127 shares at a strike of $9.00 and sold $1,141,514 worth of shares (9,127 units at $125.07) (SEC Form 4)4 - Axsome Therapeutics, Inc. (0001579428) (Issuer)
- Director Jeffs Roger sold $1,665,228 worth of shares (13,464 units at $123.68), decreasing direct ownership by 19% to 57,510 units (SEC Form 4)4 - Axsome Therapeutics, Inc. (0001579428) (Issuer)
- Director Jeffs Roger sold $7,303,400 worth of shares (60,000 units at $121.72), decreasing direct ownership by 46% to 70,974 units (SEC Form 4)4 - Axsome Therapeutics, Inc. (0001579428) (Issuer)
- Director Jeffs Roger sold $4,405,216 worth of shares (36,694 units at $120.05), decreasing direct ownership by 22% to 130,974 units (SEC Form 4)4 - Axsome Therapeutics, Inc. (0001579428) (Issuer)
- General Counsel Murdock Hunter R. exercised 13,514 shares at a strike of $29.91 and sold $1,370,647 worth of shares (13,514 units at $101.42) (SEC Form 4)4 - Axsome Therapeutics, Inc. (0001579428) (Issuer)
- General Counsel Murdock Hunter R. exercised 22,500 shares at a strike of $29.91 and sold $2,276,850 worth of shares (22,500 units at $101.19) (SEC Form 4)4 - Axsome Therapeutics, Inc. (0001579428) (Issuer)
- SEC Form 4 filed by Director Coleman Mark4 - Axsome Therapeutics, Inc. (0001579428) (Issuer)
- SEC Form 4 filed by Director Jeffs Roger4 - Axsome Therapeutics, Inc. (0001579428) (Issuer)
- SEC Form 4 filed by Director Saad Mark E4 - Axsome Therapeutics, Inc. (0001579428) (Issuer)
- Chief Operating Officer Jacobson Mark L. exercised 25,000 shares at a strike of $8.02 and sold $2,761,000 worth of shares (25,000 units at $110.44) (SEC Form 4)4 - Axsome Therapeutics, Inc. (0001579428) (Issuer)
- SEC Form 4 filed by Director Mahony Susan4 - Axsome Therapeutics, Inc. (0001579428) (Issuer)
- Director Coleman Mark sold $783,375 worth of shares (7,500 units at $104.45), decreasing direct ownership by 14% to 46,637 units (SEC Form 4)4 - Axsome Therapeutics, Inc. (0001579428) (Issuer)
- Chief Operating Officer Jacobson Mark L. exercised 40,673 shares at a strike of $6.47 and sold $4,232,636 worth of shares (40,673 units at $104.07) (SEC Form 4)4 - Axsome Therapeutics, Inc. (0001579428) (Issuer)
- Director Coleman Mark sold $322,473 worth of shares (3,000 units at $107.49), decreasing direct ownership by 5% to 54,137 units (SEC Form 4)4 - Axsome Therapeutics, Inc. (0001579428) (Issuer)
- SEC Form 4 filed by Director Mahony Susan4 - Axsome Therapeutics, Inc. (0001579428) (Issuer)
- SEC Form 4 filed by Director Jeffs Roger4 - Axsome Therapeutics, Inc. (0001579428) (Issuer)
- SEC Form 4 filed by Director Saad Mark E4 - Axsome Therapeutics, Inc. (0001579428) (Issuer)
- SEC Form 4 filed by Chief Commercial Officer Maizel Ari4 - Axsome Therapeutics, Inc. (0001579428) (Issuer)
- SEC Form 4 filed by General Counsel Murdock Hunter R.4 - Axsome Therapeutics, Inc. (0001579428) (Issuer)
- SEC Form 4 filed by Chief Financial Officer Pizzie Nick4 - Axsome Therapeutics, Inc. (0001579428) (Issuer)
- SEC Form 4 filed by Chief Operating Officer Jacobson Mark L.4 - Axsome Therapeutics, Inc. (0001579428) (Issuer)